Advertisement

Exclusive | University of Texas in FBI probe over claims Chinese government tried to illegally obtain coronavirus research

  • Staff told in an email that it was notified of the investigation last week, and researchers would be contacted about alleged role of the Houston consulate
  • Work by some of its scientists has contributed to some promising Covid-19 vaccine candidates

Reading Time:3 minutes
Why you can trust SCMP
A team at the University of Texas designed a synthetic spike protein that has been used in two vaccine candidates undergoing clinical trials in the US. Photo: Handout
An American university whose work has contributed to some promising Covid-19 vaccine candidates has been contacted by the FBI over allegations that the Chinese consulate in Houston had sought to obtain such research.
Advertisement

The University of Texas told faculty and research staff in an email on Monday that it was notified of the investigation by the FBI last week. FBI agents would contact university researchers about the alleged role of the consulate and “efforts by the Chinese government to illegally procure research from American universities, including coronavirus vaccine research”, according to the email seen by the South China Morning Post. It described this as part of an “evolving national situation”.

“We want to make you aware of an ongoing and evolving national situation that may affect some members of our research community,” read the email, which was signed by Dan Jaffe, the university’s interim executive vice-president, and Alison Preston, interim vice-president for research.

The email said the university did not know whom the FBI intended to contact or what they planned to discuss, and it had not shared anyone’s information or details about the ongoing research with FBI agents.

01:27

US consulate in Chengdu shut down in response to closure of China’s diplomatic mission in Houston

US consulate in Chengdu shut down in response to closure of China’s diplomatic mission in Houston

The university could not immediately be reached for comment on Wednesday.

Advertisement
loading
Advertisement